書籍情報から探す
Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System
ANNAMARIA BRANDLI-BAIOCCO1, EMMANUELLE BALME2, MARC BRUDER3, SUNDEEP CHANDRA4, JUERGEN HELLMANN5, MARK J.HOENERHOFF6, TAKAHITO KAMBARA7, CHRISTIAN LANDES1, BARBARA LENZ1, MARK MENSE8, SUSANNE RITTINGHAUSEN9, HIROSHI SATOH10, FREDERIC SCHORSCH11, FRANK SEELIGER12, TAKUJI TANAKA13, MINORU TSUCHITANI14, ZBIGNIEW WOJCINSKI15, THOMAS J.ROSOL16
1Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, 2Boehringer Ingelheim Pharma, 3Compugen, Inc., Nonclinical Safety, 4BioMarin Pharmaceuticals Inc., 5Merck KGaA, 6In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, 7AbbVie, Preclinical Safety, 8Covance, 9Fraunhofer ITEM, Department of Pathology, 10Iwate University, Faculty of Agriculture, 11Bayer CropScience, 12AstraZeneca Pathology, Drug Safety and Metabolism, IMED Biotech Unit, 13Tohkai Cytopathology Institute, Cancer Research and Prevention, 14LSI Medience Corporation, Nonclinical Research Center, 15Toxicology & Pathology Consulting, LLC, 16Ohio University, Department of Biomedical Sciences
Journal of Toxicologic Pathology 31 (suppl-3) 1S-95S, 2018.
1Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, 2Boehringer Ingelheim Pharma, 3Compugen, Inc., Nonclinical Safety, 4BioMarin Pharmaceuticals Inc., 5Merck KGaA, 6In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, 7AbbVie, Preclinical Safety, 8Covance, 9Fraunhofer ITEM, Department of Pathology, 10Iwate University, Faculty of Agriculture, 11Bayer CropScience, 12AstraZeneca Pathology, Drug Safety and Metabolism, IMED Biotech Unit, 13Tohkai Cytopathology Institute, Cancer Research and Prevention, 14LSI Medience Corporation, Nonclinical Research Center, 15Toxicology & Pathology Consulting, LLC, 16Ohio University, Department of Biomedical Sciences
Journal of Toxicologic Pathology 31 (suppl-3) 1S-95S, 2018.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
Nonproliferative and Proliferative Lesions of the Rat and Mouse Special Sense Organs (Ocular [eye and glands] , Olfactory and Otic)
MEG FERRELL RAMOS1,(a), JULIA BAKER2,(a), ELKE-ASTRID ATZPODIEN3,(a), UTE BACH4,(a), JACQUELINE BRASSARD5,(a), JAMES CARTWRIGHT6,(a), CYNTHIA FARMAN7,(a), CINDY FISHMAN8,(a),(b), MATT JACOBSEN6,(a), URSULA JUNKER-WALKER9,(d), FRIEKE KUPER10,(c), MARIA CECILIA REY MORENO11,(b), SUSANNE RITTINGHAUSEN12,(c), KEN SCHAFER13,(a),(d), KOHJI TANAKA14,(a), LEANDRO TEIXEIRA15,(a), KATSUHIKO YOSHIZAWA16,(a), HUI ZHANG17,(a)
(a)Member of eye subgroup, (b)Member of glands of the eye subgroup, (c)Member of olfactory subgroup, (d)Member of otic subgroup, 1AbbVie, Inc., 2Charles River Laboratories, Inc., 3F. Hoffman-La Roche Ltd., 4Bayer AG, 5Tustin, 6AstraZeneca, 7Farman Pathology, 8GlaxoSmithKline, 9Novartis, 10Retired; formerly The Netherlands Organization for Applied Scientific Research (TNO), 11BASF SE, 12Fraunhofer Institute, 13Vet Path Services, Inc., 14Nippon Boehringer Ingelheim, 15University of Wisconsin-Madison, 16Mukogawa Women's University, 17Lund
Journal of Toxicologic Pathology 31 (suppl-3) 97S-214S, 2018.
(a)Member of eye subgroup, (b)Member of glands of the eye subgroup, (c)Member of olfactory subgroup, (d)Member of otic subgroup, 1AbbVie, Inc., 2Charles River Laboratories, Inc., 3F. Hoffman-La Roche Ltd., 4Bayer AG, 5Tustin, 6AstraZeneca, 7Farman Pathology, 8GlaxoSmithKline, 9Novartis, 10Retired; formerly The Netherlands Organization for Applied Scientific Research (TNO), 11BASF SE, 12Fraunhofer Institute, 13Vet Path Services, Inc., 14Nippon Boehringer Ingelheim, 15University of Wisconsin-Madison, 16Mukogawa Women's University, 17Lund
Journal of Toxicologic Pathology 31 (suppl-3) 97S-214S, 2018.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
